Postherpetic neuralgia remains one of the most intractable neuropathic complications following varicella-zoster reactivation. Conventional analgesics, such as gabapentinoids and tricyclic antidepressants, often provide inadequate relief or trigger intolerable systemic side effects. Consequently, clinicians increasingly investigate neurostimulation modalities to modulate aberrant spinal sensory pathways. Recent preclinical research highlights the therapeutic utility of electroacupuncture for postherpetic neuralgia, showing that targeted peripheral stimulation can suppress central neuroinflammatory cascades and alleviate hyperalgesia.

Neuroinflammatory Dynamics in Postherpetic Neuralgia

Herpes zoster nerve injury frequently initiates prolonged sensory disturbances characterized by spontaneous burning pain and severe mechanical allodynia. After initial peripheral trauma, pathological signals propagate directly into the dorsal horn of the spinal cord. In response, resident immune cells undergo phenotypic alteration. Microglia rapidly shift from a resting surveillant state into an activated proinflammatory phenotype. Activated microglia proliferate rapidly, alter their morphology, and upregulate specific surface markers such as ionized calcium-binding adaptor molecule 1. Moreover, these reactive cells release potent cytokines, including interleukin-1β and tumor necrosis factor-α. These inflammatory mediators directly enhance primary afferent neurotransmission and impair local inhibitory networks. Therefore, central sensitization develops and persists long after the original dermatomal rash heals. Interventions that silence microglial hyperactivation offer a viable therapeutic pathway for mitigating refractory neuropathic pain.

Mechanistic Role of the BDNF/TrkB Pathway

Brain-derived neurotrophic factor plays a central role in sensory processing and synaptic plasticity within the spinal cord. In healthy states, basal concentrations maintain physiological neuronal connectivity. However, following peripheral nerve damage, activated dorsal horn microglia synthesize and secrete substantial amounts of this neurotrophin. The released neurotrophic factor subsequently binds to its high-affinity receptor, tyrosine kinase receptor B, located on dorsal horn sensory neurons. Consequently, this receptor ligation triggers downstream phosphorylation cascades that disrupt neuronal chloride homeostasis. Specifically, the activation of this axis downregulates the potassium-chloride cotransporter KCC2, thereby reducing the efficacy of GABAergic and glycinergic inhibitory currents. Thus, innocuous mechanical inputs transform into severe nociceptive outputs. Modulating this pathway provides an effective biological target to interrupt neuropathic hypersensitivity.

Applying Electroacupuncture for Postherpetic Neuralgia

Researchers recently demonstrated that structured neuromodulation can reverse persistent pain behaviors in experimental models. Investigators established a robust postherpetic pain model by administering intraperitoneal resiniferatoxin, which selective destroys transient receptor potential vanilloid 1 afferents and provokes prolonged sensory hypersensitivity. Animals received repetitive electroacupuncture for postherpetic neuralgia applied to selected spinal dermatomal acupoints, specifically Xinshu (BL15) and Danshu (BL19). The treatment protocol utilized a disperse-dense frequency waveform of 2 Hz/15 Hz at an intensity of 1 mA for thirty minutes daily across four consecutive weeks. Animals receiving active electroacupuncture exhibited substantial improvements in behavioral outcomes. Specifically, the stimulation restored mechanical withdrawal thresholds and normalized thermal withdrawal latencies. These quantitative improvements confirm that repetitive peripheral electrical inputs produce enduring analgesic effects.

Suppression of Spinal Microglial Activation and Cytokine Release

To identify the cellular mechanisms underlying these behavioral improvements, investigators performed thorough immunohistochemical and molecular evaluations. Lumbar spinal tissue analyses demonstrated marked elevations of ionized calcium-binding adaptor molecule 1 expression in untreated neuropathic animals. Conversely, therapeutic stimulation dramatically attenuated this microglial activation marker. Furthermore, quantitative enzyme-linked immunosorbent assays revealed significant reductions in spinal concentrations of interleukin-1β and tumor necrosis factor-α following electroacupuncture. Notably, administering exogenous recombinant neurotrophic factor intrathecally before electrical stimulation abolished these anti-inflammatory benefits. This critical finding indicates that the therapeutic effect relies upon the endogenous suppression of neurotrophin-dependent signaling. Therefore, electroacupuncture attenuates spinal neuroinflammation by targeting microglial-neuronal crosstalk.

Translational Value for Contemporary Pain Management

These laboratory discoveries provide valuable mechanistic insights for multidisciplinary pain specialists managing refractory neuralgia. Neuropathic pain management in clinical practice often struggles with patient tolerance and progressive pharmacological ceiling effects. Incorporating neuromodulatory techniques like electroacupuncture aligns with non-pharmacological recommendations supported by international pain guidelines. Although animal models cannot replicate every clinical dimension of human herpes zoster, these findings clarify how frequency-specific peripheral nerve stimulation dampens central sensitization. Modern neuromodulation devices could potentially deliver targeted bioelectrical signals that mimic these spinal neuroimmune actions. Ultimately, translating these cellular mechanisms into optimized clinical protocols can assist physicians in designing comprehensive, multi-modal care strategies for chronic neuropathic conditions.

Frequently Asked Questions

What is the therapeutic mechanism of electroacupuncture in postherpetic neuralgia?

Electroacupuncture delivers controlled electrical frequencies that stimulate sensory afferent nerve fibers. This peripheral activity suppresses microglial activation within the spinal dorsal horn, thereby lowering proinflammatory cytokines like interleukin-1β and tumor necrosis factor-α. Furthermore, it downregulates the aberrant BDNF/TrkB signaling axis, restoring normal sensory synaptic processing and attenuating centralized neuropathic pain responses.

How does microglial activation worsen neuropathic pain chronification?

Upon peripheral nerve damage, resting spinal microglia rapidly proliferate and transform into reactive inflammatory states. These activated cells release substantial quantities of proinflammatory cytokines and neurotrophic factors. Consequently, these substances alter spinal synaptic plasticity, diminish inhibitory neurotransmission, and hypersensitize second-order sensory neurons. This sequence drives persistent central sensitization and converts mild tactile sensations into agonizing neuropathic pain.

Can electroacupuncture replace pharmacological analgesics in clinical practice?

Electroacupuncture serves primarily as an integrative, adjunctive modality rather than a standalone replacement for established pharmacological agents. Clinicians frequently integrate non-pharmacological neuromodulation with systemic treatments, such as gabapentinoids, to enhance overall analgesia. Combining these modalities can reduce reliance on high-dose pharmaceuticals, minimize systemic adverse effects, and improve overall physical functioning in refractory patients.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Healthcare professionals should rely on their independent clinical judgment and verify all diagnostic and therapeutic protocols. Refer to the latest local and national guidelines for clinical practice.

References

Zhang R et al. [Effect of electroacupuncture on microglial activation in the spinal dorsal horn of rats with postherpetic neuralgia based on the BDNF/TrkB pathway]. Zhongguo Zhen Jiu. 2026 Oct 12. doi: 10.13703/j.0255-2930.20250520-0003. PMID: 42864292.

Wu Q, Zheng Y, Yu J, Ying X, Gu X, Tan Q, et al. The analgesic mechanism of electroacupuncture at the central level for neuropathic pain: a review of studies based on animal experiments. Front Neurol. 2023;14:1189620.

Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and malignant and non-malignant etiologies. Lancet Neurol. 2010;9(8):807-819.